Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema

• Status: Completed
• Trial end date: 2017-06-27
• Target enrollment: 0
• Participant gender: All

Summary

Between December 2016 and June 2017 a total of 40 eyes from 40 diabetic retinopathy patients with diabetic macular edema were recruited at the Ophthalmologic Clinic of University "G. d'Annunzio", Chieti-Pescara, Italy.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: G. d'Annunzio University
• Treatments: Dexamethasone; Ranibizumab

Criteria

Inclusion Criteria:

• Age >18 years old

• BCVA greater than 0.5 LogMAR in the study eye at baseline examination

• Presence of recent DME

• CMT > 300µm as measured using the SD-OCT at the baseline examination

Exclusion Criteria:

• Any previous ocular surgery in the last 6 months

• Laser treatments

• Prior ocular trauma

• Retinal vascular diseases

• Vitreo-retinal interface diseases

• Medium lens opacities (according to Lens Opacities Classification System)